EGFR c.643_644delinsGC ;(p.C215A)

Variant ID: 7-55220253-TG-GC

NM_005228.3(EGFR):c.643_644delinsGC;(p.C215A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors.

Nature Microbiology
Saldivia, Manuel M; Fang, Eric E; Ma, Xiaolei X; Myburgh, Elmarie E; Carnielli, Juliana B T JBT; Bower-Lepts, Christopher C; Brown, Elaine E; Ritchie, Ryan R; Lakshminarayana, Suresh B SB; Chen, Yen-Liang YL; Patra, Debjani D; Ornelas, Elizabeth E; Koh, Hazel X Y HXY; Williams, Sarah L SL; Supek, Frantisek F; Paape, Daniel D; McCulloch, Richard R; Kaiser, Marcel M; Barrett, Michael P MP; Jiricek, Jan J; Diagana, Thierry T TT; Mottram, Jeremy C JC; Rao, Srinivasa P S SPS
Publication Date: 2020-10

Variant appearance in text: EGFR: C215A
PubMed Link: 32661312
Variant Present in the following documents:
  • EMS118381-supplement-Supplementary_Information.pdf
  • EMS118381.pdf
View BVdb publication page



P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.

The Journal Of Cell Biology
Hashimoto, Ari A; Oikawa, Tsukasa T; Hashimoto, Shigeru S; Sugino, Hirokazu H; Yoshikawa, Ayumu A; Otsuka, Yutaro Y; Handa, Haruka H; Onodera, Yasuhito Y; Nam, Jin-Min JM; Oneyama, Chitose C; Okada, Masato M; Fukuda, Mitsunori M; Sabe, Hisataka H
Publication Date: 2016-04-11

Variant appearance in text: EGFR: C215A
PubMed Link: 27044891
Variant Present in the following documents:
  • JCB_201510002.pdf
View BVdb publication page



A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.

Molecular Therapy. Nucleic Acids
Liu, David V DV; Yang, Nicole J NJ; Wittrup, K Dane KD
Publication Date: 2014-05-13

Variant appearance in text: EGFR: C215A
PubMed Link: 24825362
Variant Present in the following documents:
  • Main text
  • mtna201414a.pdf
View BVdb publication page